{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:05:47Z","timestamp":1793203547679,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["BA5158\/4"],"award-info":[{"award-number":["BA5158\/4"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","award":["CS 3015-0-0"],"award-info":[{"award-number":["CS 3015-0-0"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","award":["CS 3014-0-0"],"award-info":[{"award-number":["CS 3014-0-0"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005960","name":"Deutsches Rote Kreuz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011012","name":"Society for thrombosis and hemostasis research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["493665037"],"award-info":[{"award-number":["493665037"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtha.2025.02.011","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:45:10Z","timestamp":1739969110000},"page":"1657-1666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia"],"prefix":"10.1016","volume":"23","author":[{"given":"Andreas","family":"Witzemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnalp","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Avci-Adali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Amiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Althaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zlamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.02.011_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.02.011_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.02.011_bib3","doi-asserted-by":"crossref","first-page":"095","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.02.011_bib4","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.02.011_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/hematology.2021000289","article-title":"Heparin-induced thrombocytopenia and cardiovascular surgery","volume":"2021","author":"Pishko","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.02.011_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.transci.2019.05.010","article-title":"Pre-operative therapeutic plasma exchange and intravenous immune globulin for the treatment of heparin induced thrombocytopenia in a lung transplant recipient","volume":"58","author":"Mandernach","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2025.02.011_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100089","article-title":"Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin","volume":"7","author":"Grazioli","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.02.011_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2025.02.011_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.chest.2017.03.050","article-title":"IVIg for treatment of severe refractory heparin-induced thrombocytopenia","volume":"152","author":"Padmanabhan","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.02.011_bib10","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.02.011_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(84)90324-3","article-title":"Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases","volume":"76","author":"Ochs","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.02.011_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2025.02.011_bib13","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i11.4760","article-title":"Standardization of HIT Diagnostic Assays, with K070, a chimeric human-mouse antibody, mimicking heparin dependent pathogenic antibodies","volume":"11","author":"Amiral","year":"2023","journal-title":"Med Res Arch"},{"key":"10.1016\/j.jtha.2025.02.011_bib14","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/bloodadvances.2023009661","article-title":"Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?","volume":"7","author":"Sarkar","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.02.011_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","article-title":"Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells","volume":"14","author":"Blank","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.jtha.2025.02.011_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211543","article-title":"Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease","volume":"14","author":"Ishikawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.02.011_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.02.011_bib18","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.02.011_bib19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"Johnston","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.02.011_bib20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"Hayes","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2025.02.011_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2018-02-830737","article-title":"Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia","volume":"132","author":"Dai","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.02.011_bib22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.02.011_bib23","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3324\/haematol.2022.282275","article-title":"Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia","volume":"108","author":"Zlamal","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.02.011_bib24","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200127","article-title":"Immunohistologic features of cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia","volume":"10","author":"Geeraerts","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:58:31Z","timestamp":1777618711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1538783625001072"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.011","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}